| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 1’047.86 EUR | EUR | % |
|---|
| Vortag | EUR | Datum | 20.12.2024 |
Symbiotics SICAV II - Emerging Impact Bond Fund B EUR Fonds Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 367.15% | |
| 21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
| 21Shares Stellar ETP | CH1109575535 | 216.44% | |
| 21Shares Cardano ETP | CH1102728750 | 207.61% | |
| 21Shares Sui Staking ETP | CH1360612159 | 144.26% | |
| 21Shares Aave ETP | CH1135202120 | 134.46% | |
| 21Shares Injective Staking ETP | CH1360612134 | 10.65% | |
| 21Shares Immutable ETP | CH1360612142 | -11.92% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 475.30% | |
| 21Shares Aave ETP | CH1135202120 | 332.51% | |
| 21Shares Stellar ETP | CH1109575535 | 244.32% | |
| 21Shares Cardano ETP | CH1102728750 | 209.77% | |
| 21Shares Stacks Staking ETP | CH1258969042 | 145.10% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ripple XRP ETP | CH0454664043 | 323.11% | |
| 21Shares Aave ETP | CH1135202120 | 232.41% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 181.47% | |
| 21Shares Stellar ETP | CH1109575535 | 144.11% | |
| 21Shares Crypto Mid-Cap Index ETP | CH1130675676 | 131.62% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Solana staking ETP | CH1114873776 | 1’596.10% | |
| 21Shares Ripple XRP ETP | CH0454664043 | 585.99% | |
| 21Shares Aave ETP | CH1135202120 | 494.88% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 476.42% | |
| 21Shares Bitcoin ETP | CH0454664001 | 461.88% |
Fundamentaldaten
| Valor | |
| ISIN | LU2320788479 |
| Emittent | Symbiotics |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 09.04.2021 |
| Kategorie | Anleihen Sonstige |
| Währung | EUR |
| Volumen | |
| Depotbank | CACEIS Bank, Luxembourg Branch |
| Geschäftsjahresende | 31.03. |
| Berichtsstand | 06.01.2025 |
Anlagepolitik
So investiert der Symbiotics SICAV II - Emerging Impact Bond Fund B EUR Fonds: The main objective of the Sub-Fund is to provide a Money Market Plus risk/return profile to investors resulting from economic value creation at the base of the pyramid mostly in EFMs. In particular, the objective of the Sub-Fund is to make sustainable investment within the meaning of article 9 of SFDR by focusing on businesses and projects which target LMIHs as well as MSMEs populations, with a view to fostering inclusive development impact for its clientele and long term value creation through sustainable principles (environment, social, governance) for its investors.
ETP Performance: Symbiotics SICAV II - Emerging Impact Bond Fund B EUR Fonds
| Performance 1 Jahr | 1.01 | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |